Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients Following 3 Doses of COVID-19 Vaccine

No Thumbnail Available
Authors
Liu, Z.
Alexander, J. L.
Lin, K. W.
Ahmad, T.
Pollock, K. M.
Powell, N.
Issue Date
2022-10-19
Type
Journal Article
Language
eng
Keywords
Research Projects
Organizational Units
Journal Issue
Alternative Title
Description
Citation
Gastroenterology. 2022 Oct 19:S0016-5085(22)01184-2. doi: 10.1053/j.gastro.2022.10.010.
Publisher
Elsevier
Journal
Gastroenterology
Volume
Issue
PubMed ID
ISSN
EISSN